330KRW
3.82 BKRW
64.21 BKRW
8.56 M
About POLARIS AI PHARMA
Sector
CEO
Jae-Chul Kim
Headquarters
Hwaseong
Website
Employees (FY)
164
Founded
1998
ISIN
KR7041910001
FIGI
BBG000GYZ1M2
Polaris AI Pharma Corp. engages in the manufacture and supply of pharmaceutical ingredients and fine chemicals. Its products include treatment of alcoholism, anti-inflammatory, analgesics, muscle relaxant, antiseptic, antispasmodics, anti-cataracts, capillary protectant, unnatural amino acid, anti-hepatitis, anti-parkinsonian, antihistamine, nootropic and anti-diabetics. The company was founded on December 17, 1998 and is headquartered in Hwaseong, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 041910 is 8690 KRW — it has increased by 2.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange POLARIS AI PHARMA stocks are traded under the ticker 041910.
041910 stock is 3.25% volatile and has beta coefficient of 0.84. Check out the list of the most volatile stocks — is POLARIS AI PHARMA there?
Yes, you can track POLARIS AI PHARMA financials in yearly and quarterly reports right on TradingView.
041910 stock has fallen by 1.14% compared to the previous week, the month change is a 18.56% fall, over the last year POLARIS AI PHARMA has showed a 12.56% increase.
041910 net income for the last quarter is −1.72 B KRW, while the quarter before that showed 1.05 B KRW of net income which accounts for −262.85% change. Track more POLARIS AI PHARMA financial stats to get the full picture.
Today POLARIS AI PHARMA has the market capitalization of 99.51 B, it has increased by 1.76% over the last week.
Yes, 041910 dividends are paid annually. The last dividend per share was 100.00 KRW. As of today, Dividend Yield (TTM)% is 1.17%. Tracking POLARIS AI PHARMA dividends might help you take more informed decisions.
Like other stocks, 041910 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade POLARIS AI PHARMA stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 164.00 employees. See our rating of the largest employees — is POLARIS AI PHARMA on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So POLARIS AI PHARMA technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating POLARIS AI PHARMA stock shows the neutral signal. See more of POLARIS AI PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. POLARIS AI PHARMA EBITDA is 7.66 B KRW, and current EBITDA margin is 11.93%. See more stats in POLARIS AI PHARMA financial statements.